Royalty Pharma plc Current Cash

Royalty Pharma plc (RPRX) currently reports a current cash of $810M as of June 2026. That compares with $630M in the prior-year period — up 28.5% year over year. Use the charts on this page to explore Royalty Pharma plc's current cash history and peer comparisons.

Royalty Pharma plc's current cash increased from $630M to $810M — a 28.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Royalty Pharma plc reported $810M in current cash as of June 2026. That compares with $630M in the prior-year period — up 28.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $810M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Royalty Pharma plc, and consider following RPRX for alerts when major investors trade the stock.

Royalty Pharma plc is classified in the Healthcare sector. On current cash, it currently shows $810M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RPRX with unrelated industries.